US Patent 7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors

Patent 7473787 was granted and assigned to Pfizer Limited on January, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74737870

Patent Inventor Names

Stanton McHardy0

John A. Lowe0

Date of Patent

January 6, 2009

Patent Application Number

109649310

Date Filed

October 14, 2004

Patent Citations Received

‌

US Patent 11760728 Tead inhibitors and uses thereof

‌

US Patent 12059408 Treatment of cognitive impairment associated with schizophrenia

‌

US Patent 11925651 TEAD inhibitors and uses thereof

‌

US Patent 11834435 SSTR4 agonist salts

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

The present invention relates to a series of substituted bicyclic[3.1.0]amines of the Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API